Association of programmed cell death 1 polymorphisms and systemic lupus erythematosus: A meta-analysis

Lupus

Volumn 18, Issue 1, 2009, Pages 9-15

  Lee, Y H ^a,b   Woo, J H ^a   Choi, S J ^a   Ji, J D ^a   Song, G G ^a  

^a Korea University Ansan Hospital   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Meta analysis; PDCD1; Polymorphisms; Systemic lupus erythematosus

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; LEUKOCYTE ANTIGEN; PDCD1 PROTEIN, HUMAN;

ALLELE; ARTICLE; ASIAN; CAUCASIAN; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; META ANALYSIS; MEXICO; NEGRO; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; ANTIGENS, CD; APOPTOSIS REGULATORY PROTEINS; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MEXICO; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 62749182367     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203308093923     Document Type: Article

References (24)

1. Harley, JB, Kelly, JA, Kaufman, KM. Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol 2006; 28: 119-130.
2. Okazaki, T, Wang, J. PD-1/PD-L pathway and autoimmunity. Autoimmunity 2005; 38: 353-357.
3. Nishimura, H, Minato, N, Nakano, T, Honjo, T. Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int Immunol 1998; 10: 1563-1572.
4. Lindqvist, AK, Steinsson, K, Johanneson, B, et al. A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q. J Autoimmun 2000; 14: 169-178.
5. Nishimura, H, Nose, M, Hiai, H, Minato, N, Honjo, T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999; 11: 141-151.
6. Prokunina, L, Castillejo-Lopez, C, Oberg, F, et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002; 32: 666-669.
7. Wang, SC, Chen, YJ, Ou, TT, et al. Programmed death-1 gene polymorphisms in patients with systemic lupus erythematosus in Taiwan. J Clin Immunol 2006; 26: 506-511.
8. Johansson, M, Arlestig, L, Moller, B, Rantapaa-Dahlqvist, S. Association of a PDCD1 polymorphism with renal manifestations in systemic lupus erythematosus. Arthritis Rheum 2005; 52: 1665-1669.
9. Nielsen, C, Laustrup, H, Voss, A, Junker, P, Husby, S, Lillevang, ST. A putative regulatory polymorphism in PD-1 is associated with nephropathy in a population-based cohort of systemic lupus erythematosus patients. Lupus 2004; 13: 510-516.
10. Lin, SC, Yen, JH, Tsai, JJ, et al. Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus. Arthritis Rheum 2004; 50: 770-775.
11. Prokunina, L, Gunnarsson, I, Sturfelt, G, et al. The systemic lupus erythematosus-associated PDCD1 polymorphism PD1.3A in lupus nephritis. Arthritis Rheum 2004; 50: 327-328.
12. Ferreiros-Vidal, I, Gomez-Reino, JJ, Barros, F, et al. Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects. Arthritis Rheum 2004; 50: 2590-2597.
13. Sanghera, DK, Manzi, S, Bontempo, F, Nestlerode, C, Kamboh, MI. Role of an intronic polymorphism in the PDCD1 gene with the risk of sporadic systemic lupus erythematosus and the occurrence of antiphospholipid antibodies. Hum Genet 2004; 115: 393-398.
14. Velazquez-Cruz, R, Orozco, L, Espinosa-Rosales, F, et al. Association of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus. Eur J Hum Genet 2007; 15: 336-341.
15. Ferreiros-Vidal, I, D'Alfonso, S, Papasteriades, C, et al. Bias in association studies of systemic lupus erythematosus susceptibility due to geographical variation in the frequency of a programmed cell death 1. polymorphism across Europe. Genes Immun 2007; 8: 138-146.
16. Thorburn, CM, Prokunina-Olsson, L, Sterba, KA, et al. Association of PDCD1 genetic variation with risk and clinical manifestations of systemic lupus erythematosus in a multiethnic cohort. Genes Immun 2007; 8: 279-287.
17. Egger, M, Smith, GD, Phillips, AN. Meta-analysis: principles and procedures. BMJ 1997; 315: 1533-1537.
18. Egger, M, Davey, SG, Schneider, M, Minder, C. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
19. Duval, S, Tweedie, R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455-463.
20. Davey, SG, Egger, M. Meta-analyses of randomised controlled trials. Lancet 1997; 350: 1182.
21. Higgins, JP, Thompson, SG. Quantifying heterogeneity in a metaanalysis. Stat Med 2002; 21: 1539-1558.
22. Der Simonian, R, Laird, N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
23. Bonferroni, CE. Il calcolo delle assicurazioni su gruppi di teste. In: Studi in Onore del Professore Salvatore Ortu Carboni [Italien]. Rome, Italy; 1935. p. 13-60.
24. Krishnan, S, Chowdhury, B, Tsokos, GC. Autoimmunity in systemic lupus erythematosus: integrating genes and biology. Semin Immunol 2006; 18: 230-243.